Mid-life predictors of cognitive impairment and dementia in type 2 diabetes mellitus: The fremantle diabetes study

Journal of Alzheimer's Disease

Volumn 42, Issue , 2014, Pages S63-S70

  Bruce, David G ^a   Davis, Wendy A ^a   Starkstein, Sergio E ^b   Davis, Timothy M ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Cardiovascular risk factors; cognitive impairment; dementia; longitudinal study; type 2 diabetes

Indexed keywords

GLUCOSE; INSULIN;

AGE; AGED; CLINICAL DEMENTIA RATING; COGNITIVE DEFECT; COHORT ANALYSIS; CONFERENCE PAPER; DEMENTIA; DIABETIC RETINOPATHY; EDUCATIONAL STATUS; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN TREATMENT; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MINI MENTAL STATE EXAMINATION; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK FACTOR; SMOKING; SURVIVOR; TRANSIENT ISCHEMIC ATTACK; COGNITION DISORDERS; COMPLICATION; CROSS-SECTIONAL STUDY; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; NONPARAMETRIC TEST; PREDICTIVE VALUE; PSYCHOLOGICAL RATING SCALE; RETROSPECTIVE STUDY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; COGNITION DISORDERS; CROSS-SECTIONAL STUDIES; DEMENTIA; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PREDICTIVE VALUE OF TESTS; PSYCHIATRIC STATUS RATING SCALES; RETROSPECTIVE STUDIES; RISK FACTORS; STATISTICS, NONPARAMETRIC;

EID: 84920626821     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-132654     Document Type: Conference Paper

References (35)

1. Biessels GJ, Staekenborg S, Brunner E, Brayne C, Scheltens P (2006) Risk of dementia in diabetes mellitus: A systematic review. Lancet Neurol 5, 64-74.
2. Cheng G, Huang C, Deng H, Wang H (2012) Diabetes as a risk factor for dementia and mild cognitive impairment: A meta-analysis of longitudinal studies. Intern Med J 42, 484-491.
3. Luchsinger JA, Reitz C, Patel B, Tang MX, Manly JJ, Mayeux R (2007) Relation of diabetes to mild cognitive impairment. Arch Neurol 64, 570-575.
4. XuW, Caracciolo B,Wang HX,Winblad B, Backman L, Qiu C, Fratiglioni L (2010) Accelerated progression from mild cognitive impairment to dementia in people with diabetes. Diabetes 59, 2928-2935.
5. Gould CE, Beaudreau SA, Salman H (2013) Diabetes is associated with cognitive impairment no dementia in the Aging, Demographics, and Memory Study (ADAMS). Int Psychogeriatr 25, 167-168.
6. Exalto LG, Whitmer RA, Kappele LJ, Biessels GJ (2012) An update on type 2 diabetes, vascular dementia and Alzheimer's disease. Exp Gerontol 47, 858-864.
7. Turner RC, Cull CA, Frighi V, Holman RR (1999) Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: Progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group. JAMA 281, 2005-2012.
8. Bruce DG, Davis WA, Casey GP, Starkstein SE, Clarnette RM, Foster JK, Almeida OP, Davis TM (2008) Predictors of cognitive impairment and dementia in older people with diabetes. Diabetologia 51, 241-248.
9. Xu WL, von Strauss E, Qiu CX, Winblad B, Fratiglioni L (2009) Uncontrolled diabetes increases the risk of Alzheimer's disease: A population-based cohort study. Diabetologia 52, 1031-1039.
10. Peila R, Rodriguez BL, Launer LJ, Honolulu-Asia Aging S (2002) Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study. Diabetes 51, 1256-1262.
11. XuW, Qiu C, Gatz M, Pedersen NL, Johansson B, Fratiglioni L (2009) Mid-and late-life diabetes in relation to the risk of dementia: A population-based twin study. Diabetes 58, 71-77.
12. Zilkens RR, Davis WA, Spilsbury K, Semmens JB, Bruce DG (2013) Earlier age of dementia onset and shorter survival times in dementia patients with diabetes. Am J Epidemiol 177, 1246-1254.
13. Ninomiya T, Ohara T, Hirakawa Y, Yoshida D, Doi Y, Hata J, Kanba S, Iwaki T, Kiyohara Y (2011) Midlife and latelife blood pressure and dementia in Japanese elderly: The Hisayama study. Hypertension 58, 22-28.
14. Davis TM, Zimmet P, DavisWA, Bruce DG, Fida S, Mackay IR (2000) Autoantibodies to glutamic acid decarboxylase in diabetic patients from a multi-ethnic Australian community: The Fremantle Diabetes Study. Diabet Med 17, 667-674.
15. Davis TM, Bruce DG, Davis WA (2013) Cohort profile: The Fremantle Diabetes Study. Int J Epidemiol 42, 412-421.
16. Norman PE, DavisWA, Bruce DG, Davis TM (2006) Peripheral arterial disease and risk of cardiac death in type 2 diabetes: The Fremantle Diabetes Study. Diabetes Care 29, 575-580.
17. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130, 461-470.
18. Holman CD, Bass AJ, Rouse IL, Hobbs MST (1999) Population-based linkage of health records in WA: Development of a health services research linked database. Aust NZ J Publ Hth 23, 453-459.
19. DavisTM,Hunt K, McAullay D, Chubb SA, SillarsBA, Bruce DG, Davis WA (2012) Continuing disparities in cardiovascular risk factors and complications between aboriginal and Anglo-Celt Australians with type 2 diabetes: The Fremantle Diabetes Study. Diabetes Care 35, 2005-2011.
20. Bruce DG, Davis WA, Casey GP, Starkstein SE, Clarnette RM, Almeida OP, Davis TM (2008) Predictors of cognitive decline in older individuals with diabetes. Diabetes Care 31, 2103-2107.
21. Hadjivassileva T, Thurston DE, Taylor PW (2005) Pyrrolobenzodiazepine dimers: Novel sequence-selective, DNA-interactive, cross-linking agents with activity against Gram-positive bacteria. J Antimicrob Chemother 56, 513-518.
22. Jorm AF (1994) A short form of the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): Development and cross-validation. Psychol Med 24, 145-153.
23. Li J,Wang YJ, Zhang M, Xu ZQ, Gao CY, Fang CQ, Yan JC, Zhou HD, Chongqing Ageing Study G (2011) Vascular risk factors promote conversion from mild cognitive impairment to Alzheimer disease. Neurology 76, 1485-1491.
24. Thurston DL, Middelkamp JN, Mason E (1955) The late effects of lead poisoning. J Pediatr 47, 413-423.
25. Holowach J, Thurston DL (1958) A clinical evaluation of acetazolamide (diamox) in the treatment of epilepsy in children. J Pediatr 53, 160-171.
26. Simril WA, Thurston D (1955) The normal interpediculate space in the spines of infants and children. Radiology 64, 340-347.
27. Whitmer RA, Karter AJ, Yaffe K, Quesenberry CP Jr, Selby JV (2009) Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus. JAMA 301, 1565-1572.
28. Yaffe K, Falvey CM, Hamilton N, Harris TB, Simonsick EM, Strotmeyer ES, Shorr RI, Metti A, Schwartz AV (2013) Association between hypoglycemia and dementia in a biracial cohort of older adults with diabetes mellitus. JAMA Intern Med 173, 1300-1306.
29. Davis TME, Brown SGA, Jacobs IG, Bulsara M, Bruce DG, DavisWA(2010) Determinants of severe hypoglycemia complicating type 2 diabetes: The Fremantle Diabetes Study. J Clin Endocrinol Metab 95, 2240.
30. Craft S (2007) Insulin resistance and Alzheimer's disease pathogenesis: Potential mechanisms and implications for treatment. Curr Alzheimer Res 4, 147-152.
31. Crosby-Nwaobi R, Sivaprasad S, Forbes A (2012) A systematic review of the association of diabetic retinopathy and cognitive impairment in people withType 2 diabetes. Diabetes Res Clin Pract 96, 101-110.
32. Patton N, Aslam T, Macgillivray T, Pattie A, Deary IJ, Dhillon B(2005) Retinal vascular image analysis as a potential screening tool for cerebrovascular disease: A rationale based on homology between cerebral and retinal microvasculatures. J Anat 206, 319-348.
33. Cheung N, Mosley T, Islam A, Kawasaki R, Sharrett AR, Klein R, Coker LH, Knopman DS, Shibata DK, Catellier D, Wong TY (2010) Retinal microvascular abnormalities and subclinical magnetic resonance imaging brain infarct: A prospective study. Brain 133, 1987-1993.
34. Moreno-Gonzalez I, Estrada LD, Sanchez-Mejias E, Soto C (2013) Smoking exacerbates amyloid pathology in a mouse model of Alzheimer's disease. Nat Commun 4, 1495.
35. Rusanen M, Kivipelto M, Quesenberry CP Jr, Zhou J, Whitmer RA (2011) Heavy smoking in midlife and long-term risk of Alzheimer disease and vascular dementia. Arch Intern Med 171, 333-339.